Allogeneic Hematopoietic Stem Cell Transplantation Using Reduced-Intensity Conditioning for Adult T Cell Leukemia/Lymphoma: Impact of Antithymocyte Globulin on Clinical Outcome

Ryuji Tanosaki, Naokuni Uike, Atae Utsunomiya, Yoshio Saburi, Masato Masuda, Masao Tomonaga, Tetsuya Eto, Michihiro Hidaka, Mine Harada, Ilseung Choi, Takeharu Yamanaka, Mari Kannagi, Masao Matsuoka, Jun Okamura

Research output: Contribution to journalArticle

43 Citations (Scopus)

Abstract

Allogeneic hematopoietic stem cell transplantation (HSCT) is an effective treatment for adult T cell leukemia/lymphoma (ATLL), but shows high mortality. We evaluated the feasibility of reduced-intensity transplantation using fludarabine and busulfan, with particular focus on the clinical impact of antithymocyte globulin (ATG) in the conditioning regimen. Fourteen elderly patients with aggressive ATLL were enrolled in the current study without ATG, and were compared to those in 15 patients who were treated similarly, but with ATG, in our previous study. Engraftment was prompt, and treatment was tolerable. Overall (OS) and progression-free survival (PFS) at 3 years were 36% and 31%, respectively. HTVL-1 proviral load became undetectable by the polymerase chain reaction in 62% of patients. Compared to the previous study with ATG, complete donor chimera was significantly delayed. Although early relapse tended to be decreased, OS or PFS was not improved significantly. Analysis of combined data from both our current and previous studies disclosed that grade I-II acute GVHD was the only factor that favorably affected OS and PFS. These data suggested the presence of a graft-versus-ATLL effect and the feasibility of a transplant procedure without ATG in elderly ATLL patients, but could not demonstrate the clinical benefit of incorporating ATG.

Original languageEnglish
Pages (from-to)702-708
Number of pages7
JournalBiology of Blood and Marrow Transplantation
Volume14
Issue number6
DOIs
Publication statusPublished - 2008 Jun
Externally publishedYes

Fingerprint

Adult T Cell Leukemia Lymphoma
Antilymphocyte Serum
Hematopoietic Stem Cell Transplantation
Disease-Free Survival
Transplants
Busulfan
Transplantation
Tissue Donors
Recurrence
Polymerase Chain Reaction
Mortality
Therapeutics

Keywords

  • Adult T cell leukemia/lymphoma
  • Allogeneic
  • Antityymocyte globulin
  • Graft-versus-ATLL effect
  • Hematopoietic stem cell transplantation
  • Reduced-intensity transplantation

ASJC Scopus subject areas

  • Transplantation

Cite this

Allogeneic Hematopoietic Stem Cell Transplantation Using Reduced-Intensity Conditioning for Adult T Cell Leukemia/Lymphoma : Impact of Antithymocyte Globulin on Clinical Outcome. / Tanosaki, Ryuji; Uike, Naokuni; Utsunomiya, Atae; Saburi, Yoshio; Masuda, Masato; Tomonaga, Masao; Eto, Tetsuya; Hidaka, Michihiro; Harada, Mine; Choi, Ilseung; Yamanaka, Takeharu; Kannagi, Mari; Matsuoka, Masao; Okamura, Jun.

In: Biology of Blood and Marrow Transplantation, Vol. 14, No. 6, 06.2008, p. 702-708.

Research output: Contribution to journalArticle

Tanosaki, R, Uike, N, Utsunomiya, A, Saburi, Y, Masuda, M, Tomonaga, M, Eto, T, Hidaka, M, Harada, M, Choi, I, Yamanaka, T, Kannagi, M, Matsuoka, M & Okamura, J 2008, 'Allogeneic Hematopoietic Stem Cell Transplantation Using Reduced-Intensity Conditioning for Adult T Cell Leukemia/Lymphoma: Impact of Antithymocyte Globulin on Clinical Outcome', Biology of Blood and Marrow Transplantation, vol. 14, no. 6, pp. 702-708. https://doi.org/10.1016/j.bbmt.2008.03.010
Tanosaki, Ryuji ; Uike, Naokuni ; Utsunomiya, Atae ; Saburi, Yoshio ; Masuda, Masato ; Tomonaga, Masao ; Eto, Tetsuya ; Hidaka, Michihiro ; Harada, Mine ; Choi, Ilseung ; Yamanaka, Takeharu ; Kannagi, Mari ; Matsuoka, Masao ; Okamura, Jun. / Allogeneic Hematopoietic Stem Cell Transplantation Using Reduced-Intensity Conditioning for Adult T Cell Leukemia/Lymphoma : Impact of Antithymocyte Globulin on Clinical Outcome. In: Biology of Blood and Marrow Transplantation. 2008 ; Vol. 14, No. 6. pp. 702-708.
@article{3a89bd1295e44f638a5245b0cd00859c,
title = "Allogeneic Hematopoietic Stem Cell Transplantation Using Reduced-Intensity Conditioning for Adult T Cell Leukemia/Lymphoma: Impact of Antithymocyte Globulin on Clinical Outcome",
abstract = "Allogeneic hematopoietic stem cell transplantation (HSCT) is an effective treatment for adult T cell leukemia/lymphoma (ATLL), but shows high mortality. We evaluated the feasibility of reduced-intensity transplantation using fludarabine and busulfan, with particular focus on the clinical impact of antithymocyte globulin (ATG) in the conditioning regimen. Fourteen elderly patients with aggressive ATLL were enrolled in the current study without ATG, and were compared to those in 15 patients who were treated similarly, but with ATG, in our previous study. Engraftment was prompt, and treatment was tolerable. Overall (OS) and progression-free survival (PFS) at 3 years were 36{\%} and 31{\%}, respectively. HTVL-1 proviral load became undetectable by the polymerase chain reaction in 62{\%} of patients. Compared to the previous study with ATG, complete donor chimera was significantly delayed. Although early relapse tended to be decreased, OS or PFS was not improved significantly. Analysis of combined data from both our current and previous studies disclosed that grade I-II acute GVHD was the only factor that favorably affected OS and PFS. These data suggested the presence of a graft-versus-ATLL effect and the feasibility of a transplant procedure without ATG in elderly ATLL patients, but could not demonstrate the clinical benefit of incorporating ATG.",
keywords = "Adult T cell leukemia/lymphoma, Allogeneic, Antityymocyte globulin, Graft-versus-ATLL effect, Hematopoietic stem cell transplantation, Reduced-intensity transplantation",
author = "Ryuji Tanosaki and Naokuni Uike and Atae Utsunomiya and Yoshio Saburi and Masato Masuda and Masao Tomonaga and Tetsuya Eto and Michihiro Hidaka and Mine Harada and Ilseung Choi and Takeharu Yamanaka and Mari Kannagi and Masao Matsuoka and Jun Okamura",
year = "2008",
month = "6",
doi = "10.1016/j.bbmt.2008.03.010",
language = "English",
volume = "14",
pages = "702--708",
journal = "Biology of Blood and Marrow Transplantation",
issn = "1083-8791",
publisher = "Elsevier Inc.",
number = "6",

}

TY - JOUR

T1 - Allogeneic Hematopoietic Stem Cell Transplantation Using Reduced-Intensity Conditioning for Adult T Cell Leukemia/Lymphoma

T2 - Impact of Antithymocyte Globulin on Clinical Outcome

AU - Tanosaki, Ryuji

AU - Uike, Naokuni

AU - Utsunomiya, Atae

AU - Saburi, Yoshio

AU - Masuda, Masato

AU - Tomonaga, Masao

AU - Eto, Tetsuya

AU - Hidaka, Michihiro

AU - Harada, Mine

AU - Choi, Ilseung

AU - Yamanaka, Takeharu

AU - Kannagi, Mari

AU - Matsuoka, Masao

AU - Okamura, Jun

PY - 2008/6

Y1 - 2008/6

N2 - Allogeneic hematopoietic stem cell transplantation (HSCT) is an effective treatment for adult T cell leukemia/lymphoma (ATLL), but shows high mortality. We evaluated the feasibility of reduced-intensity transplantation using fludarabine and busulfan, with particular focus on the clinical impact of antithymocyte globulin (ATG) in the conditioning regimen. Fourteen elderly patients with aggressive ATLL were enrolled in the current study without ATG, and were compared to those in 15 patients who were treated similarly, but with ATG, in our previous study. Engraftment was prompt, and treatment was tolerable. Overall (OS) and progression-free survival (PFS) at 3 years were 36% and 31%, respectively. HTVL-1 proviral load became undetectable by the polymerase chain reaction in 62% of patients. Compared to the previous study with ATG, complete donor chimera was significantly delayed. Although early relapse tended to be decreased, OS or PFS was not improved significantly. Analysis of combined data from both our current and previous studies disclosed that grade I-II acute GVHD was the only factor that favorably affected OS and PFS. These data suggested the presence of a graft-versus-ATLL effect and the feasibility of a transplant procedure without ATG in elderly ATLL patients, but could not demonstrate the clinical benefit of incorporating ATG.

AB - Allogeneic hematopoietic stem cell transplantation (HSCT) is an effective treatment for adult T cell leukemia/lymphoma (ATLL), but shows high mortality. We evaluated the feasibility of reduced-intensity transplantation using fludarabine and busulfan, with particular focus on the clinical impact of antithymocyte globulin (ATG) in the conditioning regimen. Fourteen elderly patients with aggressive ATLL were enrolled in the current study without ATG, and were compared to those in 15 patients who were treated similarly, but with ATG, in our previous study. Engraftment was prompt, and treatment was tolerable. Overall (OS) and progression-free survival (PFS) at 3 years were 36% and 31%, respectively. HTVL-1 proviral load became undetectable by the polymerase chain reaction in 62% of patients. Compared to the previous study with ATG, complete donor chimera was significantly delayed. Although early relapse tended to be decreased, OS or PFS was not improved significantly. Analysis of combined data from both our current and previous studies disclosed that grade I-II acute GVHD was the only factor that favorably affected OS and PFS. These data suggested the presence of a graft-versus-ATLL effect and the feasibility of a transplant procedure without ATG in elderly ATLL patients, but could not demonstrate the clinical benefit of incorporating ATG.

KW - Adult T cell leukemia/lymphoma

KW - Allogeneic

KW - Antityymocyte globulin

KW - Graft-versus-ATLL effect

KW - Hematopoietic stem cell transplantation

KW - Reduced-intensity transplantation

UR - http://www.scopus.com/inward/record.url?scp=43649083439&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=43649083439&partnerID=8YFLogxK

U2 - 10.1016/j.bbmt.2008.03.010

DO - 10.1016/j.bbmt.2008.03.010

M3 - Article

C2 - 18489996

AN - SCOPUS:43649083439

VL - 14

SP - 702

EP - 708

JO - Biology of Blood and Marrow Transplantation

JF - Biology of Blood and Marrow Transplantation

SN - 1083-8791

IS - 6

ER -